These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2648479

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Breast disease: tissue characterization with Gd-DTPA enhancement profiles.
    Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT.
    Radiology; 1990 Feb; 174(2):491-4. PubMed ID: 2296657
    [Abstract] [Full Text] [Related]

  • 3. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography.
    Hachiya J, Seki T, Okada M, Nitatori T, Korenaga T, Furuya Y.
    Radiat Med; 1991 Feb; 9(6):232-40. PubMed ID: 1668410
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The MRT of the breast with 2D-spin-echo and gradient-echo sequences in diagnostically problematic cases].
    Allgayer B, Lukas P, Loos W, Kersting-Sommerhoff B.
    Rofo; 1993 May; 158(5):423-7. PubMed ID: 8490150
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [MRT of bladder carcinoma: tumor staging and gadolinium contrast behavior].
    Doringer E, Joos H, Forstner R, Schmoller H.
    Rofo; 1991 Apr; 154(4):357-63. PubMed ID: 1850149
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
    Hess T, Knopp MV, Hoffmann U, Brix G, Junkermann H, Zuna I, von Fournier D, van Kaick G.
    Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR, Press GA.
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
    Russell EJ, Schaible TF, Dillon W, Drayer B, LiPuma J, Mancuso A, Maravilla K, Goldstein HA.
    AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
    [Abstract] [Full Text] [Related]

  • 18. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
    Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, Toyoshima S, Kuroki S, Ohno S.
    Radiology; 1996 Sep; 200(3):639-49. PubMed ID: 8756909
    [Abstract] [Full Text] [Related]

  • 19. Gd-DTPA-enhanced MR imaging of spinal tumors.
    Parizel PM, Balériaux D, Rodesch G, Segebarth C, Lalmand B, Christophe C, Lemort M, Haesendonck P, Niendorf HP, Flament-Durand J.
    AJR Am J Roentgenol; 1989 May; 152(5):1087-96. PubMed ID: 2705343
    [Abstract] [Full Text] [Related]

  • 20. Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images.
    Tien RD, Brasch RC, Jackson DE, Dillon WP.
    Radiology; 1989 Sep; 172(3):791-2. PubMed ID: 2772189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.